CTXL Activators
CTXL, also known as V-set and immunoglobulin domain-containing 2 (VSIG2), is a protein encoded by the human genome that has garnered attention in the scientific community. Although not extensively characterized, the protein is predicted to be an integral component of the plasma membrane, according to data provided by Alliance of Genome Resources. The expression of CTXL has been documented to have biased prevalence in certain tissues, including the stomach and colon. This suggests a specialized role for CTXL in the physiological functions associated with these tissues, although the exact functions are yet to be fully elucidated. Understanding what can stimulate the expression of CTXL is a significant area of interest, as such knowledge could provide insights into its biological roles and the wider cellular pathways it may be involved in.
A spectrum of chemical compounds holds the potential to act as activators for the expression of CTXL. These activators could stimulate the cellular mechanisms that result in the increased production of the CTXL protein. For instance, compounds like retinoic acid and Vitamin D3 are known to interact with their specific receptors and could trigger gene expression cascades that include CTXL. Hormones such as estradiol and testosterone might selectively enhance CTXL expression by interacting with their respective hormone receptors, which function as transcription factors. Additionally, forskolin, known for its ability to raise intracellular cAMP levels, could indirectly stimulate CTXL expression by activating protein kinase A, which in turn can influence gene transcription pathways. Other molecules like hydrocortisone, epidermal growth factor (EGF), and transforming growth factor-beta (TGF-beta) also have the potential to increase CTXL expression by engaging in complex signaling pathways that ultimately lead to changes in genetic transcription. It's important to note that while these compounds can alter the expression of genes within cells, their specific effects on CTXL expression would necessitate rigorous experimental validation to establish a definitive link.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its active metabolite, binds to retinoic acid receptors, potentially triggering a cascade that culminates in the upsurge of CTXL transcription within cellular nuclei. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Upon conversion to its hormonally active form, calcitriol, Cholecalciferol engages with its receptor to prompt a transcriptional response that may encompass the enhancement of CTXL gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol binds selectively to estrogen receptors, which could stimulate the transcriptional machinery to increase levels of CTXL mRNA in a tissue-specific context. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by elevating intracellular cAMP, could activate protein kinase A, and sequentially, transcription factors that stimulate the expression of the CTXL gene. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $41.00 $77.00 $153.00 | ||
Triiodothyronine may engage thyroid hormone receptors that, when bound to DNA response elements, could initiate the synthesis of CTXL. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin may trigger the phosphorylation of intracellular signaling intermediates that converge on transcriptional activators, which could enhance CTXL expression. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone might initiate contact with glucocorticoid receptors, leading to a conformational shift that allows for the targeted upregulation of CTXL transcription. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS, recognized by toll-like receptors, could activate a nuclear factor pathway that leads to the heightened synthesis of CTXL in immune-related cells. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPAR-gamma agonist, Pioglitazone could trigger receptor-dependent DNA binding and subsequent transcriptional initiation, potentially including the upregulation of CTXL expression. | ||||||